Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

NCT02100969 is registered in ClinicalTrials.gov with Mazen Dimachkie, MD as lead sponsor.

NCT NCT02100969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02100969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Lead sponsor
Mazen Dimachkie, MD
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2015
Completion date
January 31, 2018
Enrollment
23 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

myasthenia gravis